Europe Male Infertility Market Forecast 2023-2032
KEY FINDINGS
The Europe male infertility market is projected to propel with a 4.29% CAGR between the forecast years 2023 to 2032. Widespread adoption of affordable therapies and devices, increased utilization of assisted reproductive technologies, reimbursement coverages, presence of key market players, large patient base, R&D investments, and EMA approvals drive market growth.
MARKET INSIGHTS
The Europe male infertility market growth evaluation includes a thorough study of Belgium, France, Germany, Poland, Spain, the United Kingdom, Italy, and Rest of Europe. Male infertility problems in France are expected to be boosted by high infertility rates, increasing prevalence of diabetes and lifestyle-related diseases, growing stress levels, increasing smoking rates, and rising cases of prostate cancer. Moreover, the increasing prevalence of diabetes in France further negatively impacts male fertility, with an expected rise in the number of diabetes cases by 2030 and 2045.
In Italy, the male infertility market is expected to expand due to increasing cases of male infertility related to lifestyle changes, diet, pollution, stress, and obesity. Stress, anxiety, and health issues also contribute to the market dynamics. The incidence of prostate cancer is rising in Italy, impacting sperm motility due to inflammation and bladder issues. A study reveals a decline in male fertility compared to female fertility, with socioeconomic status playing a significant role. Additionally, moderate alcohol consumption positively correlates with semen volume, sperm concentration, and total sperm count. These factors are anticipated to drive the market growth in Italy.
COMPETITIVE INSIGHTS
Key companies are Endo International PLC, Andrology Solutions, Vitrolife, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Methodology
- 1.3. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 2.3. Scope Of Study
- 2.4. Crisis Scenario Analysis
- 2.5. Major Market Findings
- 2.5.1. Product Developments And Launches By Market Players Promote Market Growth
- 2.5.2. Prevalence Of Diabetes And Cancer
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Surging Infertility Incidences
- 3.1.2. Assisted Reproductive Technology Adoption
- 3.1.3. Technological Advancements
- 3.2. Key Restraints
- 3.2.1. High Treatment Costs
- 4. Key Analytics
- 4.1. Key Market Trends
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Buyers Power
- 4.2.2. Suppliers Power
- 4.2.3. Substitution
- 4.2.4. New Entrants
- 4.2.5. Industry Rivalry
- 4.3. Growth Prospect Mapping
- 4.4. Market Maturity Analysis
- 4.5. Market Concentration Analysis
- 5. Market By Test Type
- 5.1. Dna Fragmentation Technique
- 5.2. Oxidative Stress Analysis
- 5.3. Microscopic Examination
- 5.4. Sperm Agglutination
- 5.5. Computer-assisted Semen Analysis
- 5.6. Sperm Penetration Assay
- 5.7. Other Test Types
- 6. Market By Treatment
- 6.1. Assisted Reproductive Technology And Surgery
- 6.2. Medications
- 7. Geographical Analysis
- 7.1. Europe
- 7.1.1. Market Size & Estimates
- 7.1.2. Europe Male Infertility Market Drivers
- 7.1.3. Europe Male Infertility Market Challenges
- 7.1.4. Key Players In Europe Male Infertility Market
- 7.1.5. Country Analysis
- 7.1.5.1. United Kingdom
- 7.1.5.1.1. United Kingdom Male Infertility Market Size & Opportunities
- 7.1.5.2. Germany
- 7.1.5.2.1. Germany Male Infertility Market Size & Opportunities
- 7.1.5.3. France
- 7.1.5.3.1. France Male Infertility Market Size & Opportunities
- 7.1.5.4. Italy
- 7.1.5.4.1. Italy Male Infertility Market Size & Opportunities
- 7.1.5.5. Spain
- 7.1.5.5.1. Spain Male Infertility Market Size & Opportunities
- 7.1.5.6. Belgium
- 7.1.5.6.1. Belgium Male Infertility Market Size & Opportunities
- 7.1.5.7. Poland
- 7.1.5.7.1. Poland Male Infertility Market Size & Opportunities
- 7.1.5.8. Rest Of Europe
- 7.1.5.8.1. Rest Of Europe Male Infertility Market Size & Opportunities
- 8. Competitive Landscape
- 8.1. Key Strategic Developments
- 8.1.1. Mergers & Acquisitions
- 8.1.2. Product Launches & Developments
- 8.1.3. Partnerships & Agreements
- 8.1.4. Business Expansions
- 8.2. Company Profiles
- 8.2.1. Advacare Pharma Usa
- 8.2.1.1. Company Overview
- 8.2.1.2. Products / Services List
- 8.2.2. Andrology Solutions
- 8.2.2.1. Company Overview
- 8.2.2.2. Products / Services List
- 8.2.3. Aytu Biopharma
- 8.2.3.1. Company Overview
- 8.2.3.2. Products / Services List
- 8.2.3.3. Strengths & Challenges
- 8.2.4. Bayer Group
- 8.2.4.1. Company Overview
- 8.2.4.2. Products / Services List
- 8.2.4.3. Strengths & Challenges
- 8.2.5. Caerus Biotech
- 8.2.5.1. Company Overview
- 8.2.5.2. Products / Services List
- 8.2.6. Cinnagen Co
- 8.2.6.1. Company Overview
- 8.2.6.2. Products / Services List
- 8.2.6.3. Strengths & Challenges
- 8.2.7. Emd Serono Inc (Merck Serono)
- 8.2.7.1. Company Overview
- 8.2.7.2. Products / Services List
- 8.2.7.3. Strengths & Challenges
- 8.2.8. Endo International Plc
- 8.2.8.1. Company Overview
- 8.2.8.2. Products / Services List
- 8.2.8.3. Strengths & Challenges
- 8.2.9. Halotech Dna
- 8.2.9.1. Company Overview
- 8.2.9.2. Products / Services List
- 8.2.10. Laboratory Corporation Of America Holdings
- 8.2.10.1. Company Overview
- 8.2.10.2. Products / Services List
- 8.2.10.3. Strengths & Challenges
- 8.2.11. Sanofi
- 8.2.11.1. Company Overview
- 8.2.11.2. Products / Services List
- 8.2.11.3. Strengths & Challenges
- 8.2.12. Scsa Diagnostics
- 8.2.12.1. Company Overview
- 8.2.12.2. Products / Services List
- 8.2.13. Theramex
- 8.2.13.1. Company Overview
- 8.2.13.2. Products / Services List
- 8.2.14. Vitrolife
- 8.2.14.1. Company Overview
- 8.2.14.2. Products / Services List
- 8.2.14.3. Strengths & Challenges
- 8.2.15. Zydus Lifesciences Ltd (Cadila Healthcare Ltd)
- 8.2.15.1. Company Overview
- 8.2.15.2. Products / Services List
- 8.2.15.3. Strengths & Challenges
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook